AUTHOR=Sun Fengli TITLE=A real−world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib JOURNAL=Frontiers in Oncology VOLUME=14 YEAR=2024 URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1491167 DOI=10.3389/fonc.2024.1491167 ISSN=2234-943X